| scholarly article | Q13442814 |
| P2093 | author name string | Katherine D Crew | |
| Rita Kukafka | |||
| Xinyi Jiang | |||
| Margaret Sin | |||
| Julia E McGuinness | |||
| Thomas Silverman | |||
| P2860 | cites work | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model | Q57177092 |
| Risk factors for breast cancer in women with proliferative breast disease | Q70045791 | ||
| Screening for breast cancer: an update for the U.S. Preventive Services Task Force | Q24615837 | ||
| Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society | Q27347760 | ||
| Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study | Q28281843 | ||
| Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis | Q30431831 | ||
| Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women | Q30501421 | ||
| Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer | Q34110074 | ||
| Implementation in a large health system of a program to identify women at high risk for breast cancer | Q34638053 | ||
| Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older | Q35023437 | ||
| Rating the risk factors for breast cancer | Q35099668 | ||
| Awareness of breast density and its impact on breast cancer detection and risk | Q36002291 | ||
| Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial | Q36634556 | ||
| Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
| Risk prediction models of breast cancer: a systematic review of model performances | Q37955078 | ||
| Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database | Q39453537 | ||
| Projecting individualized absolute invasive breast cancer risk in African American women | Q40149673 | ||
| The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention | Q43044965 | ||
| Physician Adherence to Breast Cancer Screening Recommendations | Q43752540 | ||
| Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention | Q44387502 | ||
| Barriers to minority participation in breast carcinoma prevention trials | Q44654075 | ||
| Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial | Q44659430 | ||
| Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. | Q46247618 | ||
| Breast cancer risk assessment in indigent women at a public hospital | Q46902228 | ||
| Exemestane for breast-cancer prevention in postmenopausal women | Q48657440 | ||
| Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women | Q49571883 | ||
| Validation studies for models projecting the risk of invasive and total breast cancer incidence | Q50651945 | ||
| P921 | main subject | electronic health records | Q10871684 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | JCO Clinical Cancer Informatics | Q85770379 |
| P1476 | title | Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report | |
| P478 | volume | 3 |
| Q93190413 | Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention | cites work | P2860 |
Search more.